AU2540897A - Methods and compositions of chimeric polypeptides for tumor antigen vaccines - Google Patents

Methods and compositions of chimeric polypeptides for tumor antigen vaccines

Info

Publication number
AU2540897A
AU2540897A AU25408/97A AU2540897A AU2540897A AU 2540897 A AU2540897 A AU 2540897A AU 25408/97 A AU25408/97 A AU 25408/97A AU 2540897 A AU2540897 A AU 2540897A AU 2540897 A AU2540897 A AU 2540897A
Authority
AU
Australia
Prior art keywords
compositions
methods
tumor antigen
chimeric polypeptides
antigen vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25408/97A
Other languages
English (en)
Inventor
Arya Biragyn
Larry W Kwak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2540897A publication Critical patent/AU2540897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU25408/97A 1996-03-21 1997-03-21 Methods and compositions of chimeric polypeptides for tumor antigen vaccines Abandoned AU2540897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1383996P 1996-03-21 1996-03-21
US60013839 1996-03-21
PCT/US1997/004656 WO1997035008A1 (fr) 1996-03-21 1997-03-21 Procedes et composition de polypeptides chimeres pour des vaccins antigeniques tumoraux

Publications (1)

Publication Number Publication Date
AU2540897A true AU2540897A (en) 1997-10-10

Family

ID=21762045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25408/97A Abandoned AU2540897A (en) 1996-03-21 1997-03-21 Methods and compositions of chimeric polypeptides for tumor antigen vaccines

Country Status (2)

Country Link
AU (1) AU2540897A (fr)
WO (1) WO1997035008A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2903999A (en) 1998-03-12 1999-09-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
JP4713809B2 (ja) * 2000-04-07 2011-06-29 ユニバーシティ オブ リードズ イノベイションズ リミテッド Ｂ型肝炎コア抗原融合タンパク質
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
AU2001291050A1 (en) 2000-09-15 2002-03-26 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Viral chemokine-tumur antigen fusion proteins
EP2366709A1 (fr) * 2010-03-16 2011-09-21 BioNTech AG Vaccination anti-tumeur impliquant une réponse immunitaire humorale contre les protéines endogènes
WO2011113546A1 (fr) * 2010-03-16 2011-09-22 Biontech Ag Vaccination antitumorale suscitant une réponse immunitaire humorale dirigée contre les autoprotéines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
EP0442926A1 (fr) * 1988-11-10 1991-08-28 Imperial Cancer Research Technology Limited Polypeptides
GB8903313D0 (en) * 1989-02-14 1989-04-05 Wellcome Found Conjugates
SU1751209A1 (ru) * 1989-08-10 1992-07-30 Институт Органического Синтеза Ан Латвсср Рекомбинантна плазмидна ДНК pHIV 24-5, кодирующа слитый белок кор-антигена вируса гепатита В и белок оболочки вируса иммунодефицита человека, и штамм бактерий ЕSснеRIснIа coLI - продуцент слитого белка кор-антигена вируса гепатита В и белка оболочки вируса иммунодефицита человека
GB8920357D0 (en) * 1989-09-08 1989-10-25 Wellcome Found Peptides
NZ235315A (en) * 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
WO1995027505A1 (fr) * 1994-04-12 1995-10-19 Biomira, Inc. Antigenes specifiques d'une reponse immunitaire cellulaire et leurs utilisations

Also Published As

Publication number Publication date
WO1997035008A1 (fr) 1997-09-25

Similar Documents

Publication Publication Date Title
AU2903999A (en) Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
AU6095696A (en) Immunogenic peptides of prostate specific antigen
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
HUP0000302A3 (en) Ob fusion protein compositions and methods
AU7242994A (en) Model for testing immunogenicity of peptides
EP0958364A4 (fr) Immunotherapie et vaccins perfectionnes
AU2158995A (en) Compositions and methods for vaccines comprising alpha-galactosyl epitopes
AU4727296A (en) Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
AU4164097A (en) Compositions and methods for specifically targeting tumors
EP0704532A3 (fr) Protéines chimériques recombinantes et procédés pour leur utilisation
EP0914115A4 (fr) Methodes de neuroprotection
IL127153A0 (en) Fragments of leptin (ob protein)
EP0693931A4 (fr) Proteines et peptides immunogenes du cancer et procede d'utilisation
EP1055684A4 (fr) Derives de peptides d'antigene tumoral
AU2955195A (en) Tumor necrosis factor receptor-ii-associated protein kinase and methods for its use
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU1631700A (en) Tumor antigen-specific antibody-gp39 chimeric protein constructs
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1865297A (en) Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization
AU2540897A (en) Methods and compositions of chimeric polypeptides for tumor antigen vaccines
AU2158292A (en) Cea-binding proteins and methods for their isolation and use
AU5333298A (en) Compositions and methods for tumour therapy
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use